Neuromyelitis optica: A demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes

Multiple Sclerosis

Volumn 16, Issue 10, 2010, Pages 1156-1172

  De Parratt, John ^a   Prineas, John W ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

apoptosis; Devic's disease; glial progenitors; myelin

Indexed keywords

MYELIN;

ADULT; AGED; APOPTOSIS; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DEMYELINATING DISEASE; DEMYELINATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEURAL STEM CELL; OLIGODENDROGLIA;

ADULT; AGED; AQUAPORIN 4; ASTROCYTES; AUTOPSY; BRAIN; COMPLEMENT SYSTEM PROTEINS; DEMYELINATING DISEASES; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE REGENERATION; NEUROMYELITIS OPTICA; OLIGODENDROGLIA; OPTIC NERVE; PARAFFIN EMBEDDING; SPINAL CORD; YOUNG ADULT;

EID: 77957601341     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510382324     Document Type: Article

References (61)

1. McDonald WI, Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 ; 50: 121-127.
2. Sobel RA and Moore GRW. Demyelinating diseases. In: Love S, Louis DN, Ellison DW (eds) Greenfield's Neuropathology. Vol. 2, 8 th edn. Oxford: Oxford University Press, 2008.
3. Baker HW, Balla JI, Burger HG, Ebeling P. and Mackay IR Multiple sclerosis and autoimmune diseases. Aust N Z J Med 1972 ; 2: 256-260.
4. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ and Weinshenker BG The spectrum of neuromyelitis optica. Lancet Neurol 2007 ; 6: 805-815.
5. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004 ; 364: 2106-2112.
6. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS and Hinson SR IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005 ; 202: 473-477.
7. Takahashi T., Fujihara K., Nakashima I., et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 2006 ; 210: 307-313.
8. Fazio R., Malosio ML, Lampasona V., et al. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler 2009 ; 15: 1153-1163.
9. Hinson SR, Pittock SJ, Lucchinetti CF, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007 ; 69: 2221-2231.
10. Kinoshita M., Nakatsuji Y., Moriya M., et al. Astrocytic necrosis is induced by anti aquaporin-4 antibody-positive serum. Neuroreport 2009 ; 20: 508-512.
11. Bradl M., Misu T., Takahashi T., et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009 ; 66: 630-643.
12. Bennett JL, Lam C., Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009 ; 66: 617-629.
13. Lucchinetti CF, Mandler RN, McGavern D., et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002 ; 125: 1450-1461.
14. Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007 ; 130: 1194-1205.
15. Misu T., Fujihara K., Kakita A., et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007 ; 130: 1224-1234.
16. Misu T., Fujihara K., Nakamura M., et al. Loss of aquaporin4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 2006 ; 209: 269-275.
17. Prineas JW, Barnard RO, Kwon EE, Sharer LR and Cho ES Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993 ; 33: 137-151.
18. Prineas JW, Kwon EE, Cho ES and Sharer LR Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques. Ann N Y Acad Sci 1984 ; 436: 11-32.
19. Johnson MD, Lavin P. and Whetsell Jr WO Fulminant monophasic multiple sclerosis, Marburg's type. J Neurol Neurosurg Psychiatry 1990 ; 53: 918-921.
20. Henderson AP, Barnett MH, Parratt JD and Prineas JW Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann Neurol 2009 ; 66: 739-753.
21. Prineas JW, Kwon EE, Goldenberg PZ, Cho ES and Sharer LR Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions. Lab Invest 1990 ; 63: 624-636.
22. Prineas JW The neuropathology of multiple sclerosis. In: Koetsier JC (ed.) Handbook of Clinical Neurology-Demyelinating Diseases. Vol 1, Amsterdam: Elsevier, 1985, pp. 213-257.
23. de Vries HE Postvaccinial Perivenous Encephalitis. Amsterdam: Elselvier, 1960, pp. 57-58.
24. Bignami A. and Dahl D. Gliosis. In: Kettenmann H, Ransom BR (eds) Neuroglia. Vol 1, Oxford: Oxford University Press, 1995, pp. 843-858.
25. Barres BA, Schmid R., Sendnter M. and Raff MC Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993 ; 118: 283-295.
26. Rothenberg ME Eosinophilia. N Engl J Med 1998 ; 338: 1592-1600.
27. Colodner KJ, Montana RA, Anthony DC, Folkerth RD, De Girolami U. and Feany MB Proliferative potential of human astrocytes. J Neuropathol Exp Neurol 2005 ; 64: 163-169.
28. Scolding N., Franklin R., Stevens S., Heldin CH, Compston A. and Newcombe J. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 1998 ; 121: 2221-2228.
29. Chang A., Nishiyama A., Peterson J., Prineas J. and Trapp BD NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000 ; 20: 6404-6412.
30. Reynolds BA and Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992 ; 255: 1707-1710.
31. Laywell ED, Rakic P., Kukekov VG, Holland EC and Steindler DA Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain. Proc Natl Acad Sci U S A 2000 ; 97: 13883-13888.
32. Gensert JM and Goldman JE Heterogeneity of cycling glial progenitors in the adult mammalian cortex and white matter. J Neurobiol 2001 ; 48: 75-86.
33. Goldman JE Astrocyte lineage. In: Gazzarini RA (ed.) Myelin Biology and Disorders. Vol. 1, Amsterdam: Elselvier Academic Press, 2004, pp. 311-328.
34. Norenberg MD Astrocyte responses to CNS injury. J Neuropathol Exp Neurol 1994 ; 53: 213-220.
35. Blakemore WF and Franklin RJ Transplantation of glial cells into the CNS. Trends Neurosci 1991 ; 14: 323-327.
36. Blakemore WF and Keirstead HS The origin of remyelinating cells in the central nervous system. J Neuroimmunol 1999 ; 98: 69-76.
37. Noble M., Murray K., Stroobant P., Waterfield MD and Riddle P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 1988 ; 333: 560-562.
38. Barnett SC, Franklin RJ and Blakemore WF In vitro and in vivo analysis of a rat bipotential O-2A progenitor cell line containing the temperature- sensitive mutant gene of the SV40 large T antigen. Eur J Neurosci 1993 ; 5: 1247-1260.
39. Franklin RJ Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002 ; 3: 705-714.
40. Raine CS and Bornstein MB Experimental allergic encephalomyelitis: an ultrastructural study of experimental demyelination in vitro. J Neuropathol Exp Neurol 1970 ; 29: 177-191.
41. Raine CS, Hummelgard A., Swanson E. and Bornstein MB Multiple sclerosis: serum-induced demyelination in vitro. A light and electron microscope study. J Neurol Sci 1973 ; 20: 127-148.
42. Nair A., Frederick TJ and Miller SD Astrocytes in multiple sclerosis: a product of their environment. Cell Mol Life Sci 2008 ; 65: 2702-2720.
43. Kreutzberg GW, Blakemore WF and Graeber MB Cellular pathology of the central nervous system. In: Graham DI, Lantos PL (eds) Greenfield's Neuropathology. Vol. 1, London: Arnold, 1997, pp. 85-156.
44. Messing A. and Goldman JE Alexander Disease. In: Lazzarini RA (ed.) Myelin biology and disorders. Vol. 2, Amsterdam: Elselvier, 2004, pp. 851-866.
45. Wilke S., Thomas R., Allcock N. and Fern R. Mechanism of acute ischemic injury of oligodendroglia in early myelinating white matter: the importance of astrocyte injury and glutamate release. J Neuropathol Exp Neurol 2004 ; 63: 872-881.
46. Powers JM and McKeever PE Central pontine myelinolysis. An ultrastructural and elemental study. J Neurol Sci 1976 ; 29: 65-81.
47. Seehusen F., Orlando EA, Wewetzer K. and Baumgartner W. Vimentin-positive astrocytes in canine distemper: a target for canine distemper virus especially in chronic demyelinating lesions? Acta Neuropathol 2007 ; 114: 597-608.
48. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB and Sofroniew MV Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004 ; 24: 2143-2155.
49. Sofroniew MV Reactive astrocytes in neural repair and protection. Neuroscientist 2005 ; 11: 400-407.
50. Voskuhl RR, Peterson RS, Song B., et al. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 2009 ; 29: 11511-11522.
51. Gilson J. and Blakemore WF Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol Appl Neurobiol 1993 ; 19: 173-181.
52. Blakemore WF Ethidium bromide induced demyelination in the spinal cord of the cat. Neuropathol Appl Neurobiol 1982 ; 8: 365-375.
53. Blakemore WF, Crang AJ and Evans RJ The effect of chemical injury on oligodendrocytes. In: Mimms CC, Cuzner ML, Kelly RW (eds) Viruses and Demyelinating Diseases. Vol. 1, London: Academic Press, 1983, pp. 167-190.
54. Blakemore WF and Patterson RC Suppression of remyelination in the CNS by X-irradiation. Acta Neuropathol 1978 ; 42: 105-113.
55. Blakemore WF, Welsh CJ, Tonks P. and Nash AA Observations on demyelinating lesions induced by Theiler's virus in CBA mice. Acta Neuropathol 1988 ; 76: 581-589.
56. Franklin RJM and Goldman JE Remyelination by endogenous cells. In: Lazzarini RA (ed.) Myelin Biology and Disorders 1. Vol 1, Amsterdam: Elsevier, 2004, pp. 173-196.
57. Mignot C., Boespflug-Tanguy O., Gelot A., Dautigny A., Pham-Dinh D. and Rodriguez D. Alexander disease: putative mechanisms of an astrocytic encephalopathy. Cell Mol Life Sci 2004 ; 61: 369-385.
58. Buttery PC and ffrench-Constant C. Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes. Mol Cell Neurosci 1999 ; 14: 199-212.
59. Zhang SC, Ge B. and Duncan ID Tracing human oligodendroglial development in vitro. J Neurosci Res 2000 ; 59: 421-429.
60. Parratt JDE and Prineas JW The astrocyte lesion in neuromyelitis optica and multiple sclerosis. Mult Scler 2009 ; 15 (Suppl. 2). S174.
61. Sharma R., Fischer MT, Bauer J., et al. Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathol 120: 223-236.